Yoshihisa Kitamura Selected Research

2,2-dimethoxy-2-phenylacetophenone

1/2015

Photoinitiator-Initiated Estrogenic Activity in Human Breast Cancer Cell Line MCF-7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihisa Kitamura Research Topics

Disease

28	Parkinson Disease (Parkinson's Disease) 10/2021 - 03/2002
24	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 04/2002
13	Neoplasms (Cancer) 04/2022 - 01/2010
10	Treatment-Resistant Depressive Disorder 08/2020 - 01/2002
7	Cognitive Dysfunction 01/2021 - 10/2015
7	Amyloid Plaque 01/2012 - 04/2002
6	Brain Ischemia (Cerebral Ischemia) 01/2017 - 08/2007
5	Neuroblastoma 01/2018 - 11/2002
4	Ischemia 11/2020 - 02/2003
4	Stroke (Strokes) 11/2020 - 07/2011
4	Breast Neoplasms (Breast Cancer) 03/2020 - 01/2015
3	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2017
3	Hemorrhage 04/2022 - 01/2014
3	Inflammation (Inflammations) 01/2022 - 01/2019
3	Cerebral Hemorrhage 01/2022 - 09/2016
3	Neuroinflammatory Diseases 01/2022 - 11/2007
3	Dementia (Dementias) 10/2021 - 03/2016
3	Delirium 08/2021 - 01/2015
3	Hypothermia 01/2008 - 11/2003
2	Tauopathies 04/2022 - 06/2007
2	Necrosis 03/2021 - 01/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2020 - 01/2019
2	Constipation 01/2020 - 01/2018
2	Diarrhea 01/2020 - 01/2015
2	Pain (Aches) 01/2019 - 08/2018
2	Osteonecrosis (Kienbock's Disease) 01/2018 - 01/2015
2	Substance-Related Disorders (Drug Abuse) 01/2017 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2003
2	Hypertension (High Blood Pressure) 01/2015 - 11/2011
2	Insulin Resistance 11/2011 - 04/2010
2	Hyperinsulinism (Hyperinsulinemia) 11/2011 - 05/2008
2	Morphine Dependence 09/2011 - 03/2008
2	Opioid-Related Disorders (Opiate Addiction) 04/2011 - 03/2008
2	Infarction (Infarctions) 01/2009 - 03/2008
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2009 - 06/2008
2	Hyperglycemia 05/2008 - 12/2007
1	Febrile Neutropenia 04/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2022
1	Synucleinopathies 10/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2003
11	Amyloid (Amyloid Fibrils)IBA 04/2022 - 03/2010
11	Neuroprotective AgentsIBA 11/2020 - 02/2003
9	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 03/2002
8	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2016 - 01/2002
8	Amyloid beta-PeptidesIBA 03/2010 - 04/2002
7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2022 - 12/2008
6	AntioxidantsIBA 01/2021 - 07/2011
6	Pharmaceutical PreparationsIBA 03/2020 - 11/2003
6	Peptides (Polypeptides)IBA 01/2018 - 04/2002
5	Antidepressive Agents (Antidepressants)IBA 01/2017 - 06/2002
5	RotenoneIBA 01/2011 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 10/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 01/2019
4	Imipramine (Janimine)FDA LinkGeneric 11/2013 - 11/2003
3	Molecular Chaperones (Chaperone, Molecular)IBA 01/2017 - 03/2008
3	UCP0054278IBA 01/2017 - 03/2009
3	Pramipexole (Mirapex)FDA LinkGeneric 01/2014 - 07/2009
3	HMGB1 Protein (HMG1)IBA 01/2012 - 02/2003
2	LipidsIBA 04/2022 - 01/2015
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 08/2020
2	Thrombin FDA Link 01/2022 - 08/2020
2	CytokinesIBA 08/2020 - 06/2008
2	human ERBB2 proteinIBA 03/2020 - 01/2017
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2017
2	Magnesium Oxide (Magnesia)FDA Link 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2019 - 01/2015
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018 - 12/2007
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2018 - 03/2013
2	Denosumab FDA Link 01/2018 - 01/2015
2	Zoledronic Acid (Zometa)FDA Link 01/2018 - 01/2015
2	Nicotine FDA Link 04/2017 - 04/2011
2	Nerve Growth Factor (NGF)IBA 01/2017 - 01/2010
2	Protein Deglycase DJ-1IBA 01/2017 - 01/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015 - 04/2007
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2015 - 06/2003
2	O(4)-methylthymidine monophosphateIBA 01/2015 - 01/2013
2	Bupropion (Wellbutrin)FDA LinkGeneric 01/2014 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012 - 03/2008
2	Levodopa (L Dopa)FDA LinkGeneric 01/2012 - 03/2002
2	FructoseIBA 11/2011 - 04/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2010 - 05/2008
2	Insulin (Novolin)FDA Link 04/2010 - 05/2008
2	triphenyltetrazoliumIBA 01/2009 - 03/2008
2	Carbamazepine (Tegretol)FDA LinkGeneric 05/2008 - 04/2008
2	Serotonin (5 Hydroxytryptamine)IBA 12/2007 - 06/2002
1	Choline (Choline Chloride)IBA 04/2022
1	CefozopranIBA 04/2022
1	Cefepime (Maxipime)FDA LinkGeneric 04/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022
1	lipoxin A4IBA 01/2022
1	kaempferolIBA 10/2021
1	SynucleinsIBA 10/2021

Therapy/Procedure

8	Therapeutics 11/2019 - 03/2002
7	Drug Therapy (Chemotherapy) 04/2022 - 10/2015
3	Transplantation 01/2020 - 10/2006
3	Aftercare (After-Treatment) 08/2018 - 12/2009
2	Terminal Care (Care, Terminal) 12/2019 - 01/2017
2	Kampo Medicine (Kampo) 01/2018 - 03/2010